PCN68 COST-EFFECTIVENESS OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR THE PREVENTION OF FEBRILE NEUTROPENIA IN NON-HODGKIN LYMPHOMA AND STAGE II BREAST CANCER PATIENTS IN GERMANY

Nov 1, 2010, 00:00
10.1016/S1098-3015(11)71963-5
https://www.valueinhealthjournal.com/article/S1098-3015(11)71963-5/fulltext
Title : PCN68 COST-EFFECTIVENESS OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR THE PREVENTION OF FEBRILE NEUTROPENIA IN NON-HODGKIN LYMPHOMA AND STAGE II BREAST CANCER PATIENTS IN GERMANY
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71963-5&doi=10.1016/S1098-3015(11)71963-5
First page : A263
Section Title : RESEARCH POSTER ABSTRACTS
Open access? : No
Section Order : 121
Categories :
Tags :
Regions :
ViH Article Tags :